7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 
      
    		                           
      cash flows from operating activities:
    		                           
      net income
    		24,319,000 34,907,000 25,682,000 6,857,000 4,216,000 12,194,000 12,197,000 4,031,000 -25,422,000 -1,001,000 -2,636,000 -6,720,000 -7,426,000 -11,523,000 -10,562,000 -12,668,000 -12,962,000 -10,668,000 -7,917,000 -6,311,000 -5,088,000 -8,497,000 -8,852,000 -9,177,000 -8,280,000 -9,195,000 -6,895,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                           
      depreciation and amortization expense
    		6,849,000 6,731,000 6,137,000 5,680,000 5,177,000 4,599,000 4,302,000 3,605,000 1,893,000 1,392,000 1,287,000 1,285,000 891,000 795,000 507,000 466,000 455,000 451,000 445,000 430,000 402,000 374,000 371,000 356,000 332,000 289,000 245,000 
      stock-based compensation expense
    		9,136,000 9,372,000 8,958,000 10,767,000 7,944,000 7,643,000 6,870,000 5,724,000 5,188,000 4,958,000 3,921,000 2,991,000 2,704,000 2,316,000 2,310,000 1,985,000 1,973,000 1,808,000 1,112,000 698,000 700,000 631,000 385,000 282,000 295,000 220,000 57,000 
      non-cash interest expense and end of term accretion expense
    		796,000 791,000 787,000 784,000 780,000 775,000 772,000 770,000 765,000 487,000 106,000  31,000 141,000 137,000  137,000 134,000 130,000  130,000 126,000 123,000     
      non-cash lease expense
    		550,000 523,000 474,000 462,000 452,000 329,000 321,000 313,000 305,000 232,000 191,000 185,000 180,000 174,000 178,000             
      unrealized foreign currency transaction gains
    		                           
      loss on disposal of fixed assets
    		0 0 80,000 0                        
      changes in operating assets and liabilities
    		                           
      accounts receivable
    		24,148,000 37,518,000 -44,134,000 -7,841,000 -8,819,000 757,000 -18,407,000 -2,819,000 -11,135,000 -8,900,000 -10,962,000 -5,391,000 -9,156,000 -1,327,000 -5,804,000 -1,810,000 2,090,000 1,143,000 -583,000 -690,000 -1,663,000 1,713,000 422,000 -68,000 583,000 -1,935,000 -1,746,000 
      inventory
    		-6,902,000 3,714,000 2,003,000 4,137,000 -4,558,000 -2,319,000 -5,613,000 -7,063,000 -10,052,000 -7,354,000 -3,623,000 -1,930,000 -1,941,000 -1,227,000 -2,926,000 -930,000 -2,070,000 -1,513,000 -381,000 657,000 -988,000 -1,168,000 -241,000 -883,000 -12,000 -758,000 -2,468,000 
      prepaid expenses and other current assets
    		-5,900,000 -847,000 1,928,000 -196,000 -2,849,000 -1,641,000 -1,576,000 69,000 -2,685,000 1,399,000 -884,000 2,619,000 1,055,000 -1,241,000 88,000 -1,759,000 -183,000 -301,000 -908,000 -33,000 -412,000 -204,000 -120,000 564,000 -573,000 -158,000 417,000 
      other non-current assets
    		-6,000   -49,000 -76,000 0 -24,000 0 0 0 -54,000                 
      accounts payable
    		2,455,000 -1,191,000 781,000 -3,138,000 -36,000 3,817,000 -2,039,000 416,000 2,868,000 2,645,000 1,028,000 264,000 -1,919,000 2,398,000 -4,013,000 3,864,000 288,000 1,020,000 -82,000 615,000 -2,590,000 -1,416,000 -2,411,000 2,389,000 -388,000 684,000 758,000 
      accrued expenses and other current liabilities
    		13,141,000 2,231,000 -4,644,000 2,324,000 4,984,000 679,000 -49,000 4,993,000 5,061,000 742,000 3,454,000 3,445,000 234,000 -238,000 -4,000 2,519,000 366,000 2,170,000 -180,000 -1,372,000 2,660,000 -1,146,000 1,806,000 -501,000 2,138,000 -1,578,000 2,394,000 
      deferred revenue
    		1,735,000 -522,000 330,000 -430,000 731,000 -612,000 108,000 -682,000        -65,000 -147,000 37,000 182,000 -1,096,000 308,000   0 -6,000 -187,000 57,000 
      operating lease liabilities
    		-740,000 -714,000 -664,000 -639,000 -626,000 -504,000 -496,000 -473,000 -359,000 -390,000 -352,000 -335,000 -328,000 -323,000 1,241,000             
      net cash from operating activities
    		69,573,000 91,609,000 -2,855,000 19,663,000 6,857,000 25,718,000 -3,435,000 8,304,000 -6,868,000 -5,803,000 -8,661,000 -4,035,000 -14,282,000 -9,094,000 -18,406,000 -6,648,000 -9,350,000 -5,536,000 -7,330,000 -7,138,000 -6,412,000 -8,539,000 -8,176,000 -7,264,000 -5,597,000 -12,159,000 -7,266,000 
      capex
    		-7,076,000 -8,971,000 -25,902,000 -12,474,000 -48,813,000 -23,403,000 -42,992,000 -41,088,000 0 -1,339,000 -897,000 -3,628,000 -3,331,000 -3,872,000 -1,014,000 -2,320,000 204,000 -190,000 -13,000 -2,000 -77,000 -185,000 -165,000 98,000 38,000 -258,000 126,000 
      free cash flows
    		62,497,000 82,638,000 -28,757,000 7,189,000 -41,956,000 2,315,000 -46,427,000 -32,784,000 -6,868,000 -7,142,000 -9,558,000 -7,663,000 -17,613,000 -12,966,000 -19,420,000 -8,968,000 -9,146,000 -5,726,000 -7,343,000 -7,140,000 -6,489,000 -8,724,000 -8,341,000 -7,166,000 -5,559,000 -12,417,000 -7,140,000 
      cash flows from investing activities:
    		                           
      purchases of property, plant and equipment
    		-7,624,000 -9,075,000 -27,038,000 -13,606,000 -48,203,000 -23,763,000 -44,172,000 -41,818,000                    
      purchase of business, net of cash acquired
    		   0    0                    
      net cash from investing activities
    		-7,624,000 -9,075,000 -27,038,000 -13,606,000 -47,762,000 -23,763,000 -44,172,000 -41,818,000 -149,828,000 -1,380,000 -927,000  24,748,000 22,015,000 10,514,000  6,199,000 3,804,000 9,272,000 9,884,000 -23,473,000 -40,724,000 12,715,000 7,360,000 -18,765,000 -49,093,000 -3,000 
      cash flows from financing activities:
    		                           
      proceeds from issuance of common stock upon exercise of stock options
    		1,816,000 7,089,000 1,742,000 1,186,000 6,439,000 10,641,000 2,547,000 924,000 952,000 705,000 3,574,000 2,787,000 1,441,000 237,000 202,000 45,000 344,000 213,000 372,000 33,000 27,000 92,000 75,000 94,000 98,000 2,000 8,000 
      proceeds from issuance of common stock in connection with employee stock purchase plan
    		1,963,000 0 1,286,000 0 1,423,000 0 638,000 0 571,000 0 384,000 0 306,000 0 203,000 0 208,000 0 211,000 0 160,000 0 197,000     
      tax withholding payments related to net settlement of restricted stock units
    		                           
      net cash from financing activities
    		3,641,000 7,089,000 3,028,000 1,186,000 7,862,000 10,641,000 3,185,000 924,000 1,523,000 394,013,000 3,958,000 3,065,000 164,220,000 237,000 405,000 45,000 552,000 213,000 583,000 33,000 -179,000 75,543,000 152,000 -246,000 -2,428,000 96,094,000 -697,000 
      effect of exchange rate changes on cash and restricted cash
    		9,000 809,000 358,000                         
      net increase in cash and restricted cash
    		65,599,000                           
      cash and restricted cash, beginning of period
    		0 0 337,150,000                         
      cash and restricted cash, end of period
    		65,599,000 90,432,000 310,643,000                         
      supplemental disclosure of non-cash activities:
    		                           
      transfers of inventory to property, plant and equipment
    		1,266,000 976,000 1,275,000 1,215,000 1,207,000 2,166,000 1,215,000 2,350,000                    
      purchases of property, plant and equipment included in accounts payable and accrued expenses
    		548,000 104,000 1,136,000 1,132,000 -610,000 360,000 1,180,000 730,000                    
      operating lease liabilities arising from obtaining right-of-use assets
    		471,000   0    0 -51,000                   
      reconciliation of cash and restricted cash:
    		                           
      cash
    		65,599,000 90,432,000 310,143,000                         
      restricted cash
    		0 0 500,000  0 0 500,000 0 -250,000 0 750,000 0 0 0 500,000 0 0 0 500,000 0 0 0 500,000     
      total cash and restricted cash shown in the statement of cash flows
    		65,599,000 90,432,000 310,643,000                         
      raw materials
    		1,100,000 -5,792,000 24,949,000                         
      work-in-process
    		-2,243,000 89,000 3,791,000                         
      finished goods
    		6,781,000 1,191,000 14,640,000                         
      unrealized foreign currency transaction (gains) losses
    		 -900,000 -573,000 945,000 -480,000 1,000 199,000   -13,000 -137,000     341,000 273,000   -542,000       160,000 
      net decrease in cash and restricted cash
    		  -26,507,000                         
      acquired in-process research and development expenses
    		       0                    
      deferred taxes
    		       -120,000                    
      loss on extinguishment of debt
    		           0                
      loss on sale of marketable securities
    		           0                
      net amortization of premiums on marketable securities
    		           0 12,000 141,000 228,000 281,000 308,000 376,000 391,000    1,000     
      changes in operating assets and liabilities, net of acquired assets and liabilities:
    		                           
      purchase of in-process research and development assets
    		       0                    
      purchases of marketable securities
    		           0 -988,000 -7,475,000 -2,033,000 -5,330,000 -21,233,000 -33,753,000 -11,708,000 -20,281,000 -37,875,000 -59,469,000 -4,168,000 -14,694,000 -18,732,000   
      proceeds from sales and maturities of marketable securities
    		           0 28,666,000 33,750,000 14,500,000 18,500,000 27,500,000 37,810,000 21,000,000 30,167,000 14,458,000 18,865,000 17,160,000     
      proceeds from issuance of convertible senior notes, net of issuance costs paid of 14,620
    		       0 0                   
      purchases of capped calls related to convertible senior notes
    		       0 0                   
      proceeds from issuance of long-term debt, net of issuance costs
    		           0                
      repayments of long-term debt
    		           0                
      proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions and issuance costs paid
    		           -160,000                
      proceeds from issuance of common stock upon exercise of warrants
    		                           
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		   -687,000 386,000 -62,000 -173,000 292,000 -177,000 5,000 73,000 454,000 -610,000 -669,000 -196,000 -304,000 -220,000 106,000 -379,000 405,000 309,000 134,000 -45,000 -165,000 -45,000 185,000 -60,000 
      net increase in cash, cash equivalents and restricted cash
    		   6,556,000 -32,657,000   -32,298,000 -155,350,000   -3,280,000 174,076,000 12,489,000 -7,683,000 3,085,000 -2,819,000 -1,413,000 2,146,000 3,184,000 -29,755,000 26,414,000 4,646,000 -315,000 -26,835,000   
      cash, cash equivalents and restricted cash, beginning of period
    		   0 0 0 395,312,000 0 0 0 201,682,000 0 0 0 26,080,000 0 0 0 25,081,000 0 0 0 20,592,000 0 0 0 20,741,000 
      cash, cash equivalents and restricted cash, end of period
    		   6,556,000 -32,657,000 12,534,000 350,717,000 -32,298,000 -155,350,000 386,835,000 196,125,000 -3,280,000 174,076,000 12,489,000 18,397,000 3,085,000 -2,819,000 -1,413,000 27,227,000 3,184,000 -29,755,000 26,414,000 25,238,000 -315,000 -26,835,000 35,027,000 12,715,000 
      supplemental disclosure of cash flow information:
    		                           
      cash paid for interest
    		                           
      conversion of convertible senior notes into common stock
    		                           
      changes in operating assets and liabilities:
    		                           
      reconciliation of cash, cash equivalents and restricted cash:
    		                           
      cash and cash equivalents
    		    -32,657,000 12,534,000 350,217,000 -32,298,000 -155,100,000 386,835,000 195,375,000 -3,280,000 174,076,000 12,489,000 17,897,000 3,085,000 -2,819,000 -1,413,000 26,727,000 3,184,000 -29,755,000 26,414,000 24,738,000     
      total cash, cash equivalents and restricted cash shown in the statement of cash flows
    		    -32,657,000 12,534,000 350,717,000 -32,298,000 -155,350,000 386,835,000 196,125,000 -3,280,000 174,076,000 12,489,000 18,397,000 3,085,000 -2,819,000 -1,413,000 27,227,000 3,184,000 -29,755,000 26,414,000 25,238,000     
      net decrease in cash, cash equivalents and restricted cash
    		      -44,595,000    -5,557,000                -8,026,000 
      unrealized foreign currency transaction losses
    		            699,000 820,000 214,000    484,000   -209,000 78,000     
      proceeds from issuance of long-term debt, net of issuance costs and issuance costs paid
    		                           
      proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions
    		                   0 0       
      offering costs included in accounts payable and accrued expenses
    		                       0 -1,261,000   
      purchases of property and equipment
    		         -1,380,000 -927,000 -2,764,000 -2,930,000 -4,260,000 -1,953,000 -3,178,000 -68,000 -253,000 -20,000 -2,000 -56,000 -120,000 -277,000 19,000 -33,000 -148,000 -3,000 
      transfers of inventory to property and equipment
    		         774,000 317,000 80,000 705,000 320,000 1,030,000 888,000 170,000 336,000 429,000 486,000 627,000 0 78,000 242,000 641,000 856,000 407,000 
      purchases of property and equipment included in accounts payable and accrued expenses
    		         41,000 30,000 -864,000 -401,000 388,000 939,000 858,000 272,000 63,000 7,000         
      supplemental disclosure of non-cash investing and financing activities:
    		                           
      non-cash interest and end of term accretion expense
    		                           
      deferred rent
    		                122,000 -23,000 -23,000 44,000 266,000 361,000 262,000 -88,000 -87,000 -87,000 -87,000 
      net cash from (used) in investing activities
    		                           
      proceeds from paycheck protection program loan
    		                   0 0       
      repayment of paycheck protection program loan
    		                   0 0       
      supplemental disclosure of non-cash investing activities:
    		                           
      payments of public offering and other financing costs
    		                           
      payments of public offering costs and other financing costs
    		                    -366,000       
      change in fair value of preferred stock warrant liability
    		                       0 0 614,000 -273,000 
      net amortization (accretion) of premiums (discounts) on marketable securities
    		                   330,000 255,000   -69,000    
      conversion of convertible preferred stock to common stock upon initial public offering
    		                       0    
      reclassification of warrant liability to equity upon initial public offering
    		                       0 2,478,000   
      purchases of property and equipment included in accounts payable
    		                    -21,000 -65,000 112,000 79,000 71,000 -110,000 129,000 
      settlement of accrued financing fee
    		                       0    
      reclassification of warrants to additional paid-in capital
    		                           
      payments of initial public offering costs and other financing costs
    		                      -120,000     
      proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions
    		                       0 0   
      payments of initial public offering and other financing costs
    		                       -340,000    
      non-cash interest expense
    		                        121,000 116,000 115,000 
      payments of initial public offering costs
    		                         -1,275,000 -705,000 
      deferred offering costs included in accounts payable and accrued expenses
    		                          1,134,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.